FDA Approved: EPCLUSA — Original Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved EPCLUSA (ledipasvir/sofosbuvir) in its original application for the treatment of chronic hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Epclusa (sofosbuvir/velpatasvir)

Snippet

ORIG AP for EPCLUSA (VELPATASVIR AND SOFOSBUVIR)